Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013LEARN MORE>
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013
>Go!

SEC Filings

Form 8-K
ACTAVIS, INC. filed this Form 8-K on 01/25/2013
Document Outline
Entire Document (1309.5 KB)
Subdocument 1 - 8-K - FORM 8-K
Page 1 - UNITED STATES
Page 2 - Item 1.01. Entry into a Material Definitive Agreement.
Page 3 - Item 2.01. Completion of Acquisition or Disposition of Assets
Page 4 - Item 9.01. Financial Statements and Exhibits.
Page 5 - N/A
Page 6 - EXHIBIT INDEX
Subdocument 2 - EX-2.1 - STOCK PURCHASE AGREEMENT, DATED AS OF JANUARY 19, 2013
Page 1 - Exhibit 2.1
Page 2 - Private and confidential
Page 3 - SHARE PURCHASE AGREEMENT
Page 4 - Private and confidential
Page 5 - Private and confidential
Page 6 - Private and confidential
Page 7 - Private and confidential
Page 8 - Private and confidential
Page 9 - Private and confidential
Page 10 - Private and confidential
Page 11 - Private and confidential
Page 12 - Private and confidential
Page 13 - Private and confidential
Page 14 - Private and confidential
Page 15 - Private and confidential
Page 16 - Private and confidential
Page 17 - Private and confidential
Page 18 - Private and confidential
Page 19 - Private and confidential
Page 20 - Private and confidential
Page 21 - Private and confidential
Page 22 - Private and confidential
Page 23 - Private and confidential
Page 24 - Private and confidential
Page 25 - Private and confidential
Page 26 - Private and confidential
Page 27 - Private and confidential
Page 28 - Private and confidential
Page 29 - Private and confidential
Page 30 - Private and confidential
Page 31 - Private and confidential
Page 32 - Private and confidential
Page 33 - Private and confidential
Page 34 - Private and confidential
Page 35 - Private and confidential
Page 36 - Private and confidential
Page 37 - Private and confidential
Page 38 - Private and confidential
Page 39 - Private and confidential
Page 40 - Private and confidential
Page 41 - Private and confidential
Page 42 - Private and confidential
Page 43 - Private and confidential
Page 44 - Private and confidential
Page 45 - Private and confidential
Page 46 - Private and confidential
Page 47 - Private and confidential
Page 48 - Private and confidential
Page 49 - Private and confidential
Page 50 - Private and confidential
Page 51 - Private and confidential
Page 52 - Private and confidential
Page 53 - Private and confidential
Page 54 - Private and confidential
Page 55 - Private and confidential
Page 56 - Private and confidential
Page 57 - Private and confidential
Page 58 - Private and confidential
Page 59 - Private and confidential
Page 60 - Private and confidential
Page 61 - Private and confidential
Page 62 - Private and confidential
Page 63 - Private and confidential
Page 64 - Private and confidential
Page 65 - Private and confidential
Page 66 - Private and confidential
Page 67 - Private and confidential
Page 68 - Private and confidential
Page 69 - Private and confidential
Page 70 - Private and confidential
Page 71 - Private and confidential
Page 72 - Private and confidential
Page 73 - Private and confidential
Page 74 - Private and confidential
Page 75 - Private and confidential
Page 76 - Private and confidential
Page 77 - Private and confidential
Page 78 - Private and confidential
Page 79 - Private and confidential
Page 80 - Private and confidential
Page 81 - Private and confidential
Page 82 - Private and confidential
Page 83 - Private and confidential
Page 84 - Private and confidential
Page 85 - Private and confidential
Page 86 - Private and confidential
Page 87 - Private and confidential
Page 88 - Private and confidential
Page 89 - Private and confidential
Page 90 - Private and confidential
Page 91 - Private and confidential
Page 92 - Private and confidential
Page 93 - Private and confidential
Page 94 - Private and confidential
Page 95 - Private and confidential
Page 96 - Private and confidential
Page 97 - Private and confidential
Page 98 - Private and confidential
Page 99 - Private and confidential
Page 100 - Private and confidential
Page 101 - Private and confidential
Page 102 - Private and confidential
Page 103 - Private and confidential
Page 104 - Private and confidential
Page 105 - Private and confidential
Page 106 - Private and confidential
Page 107 - Private and confidential
Page 108 - Private and confidential
Page 109 - Private and confidential
Page 110 - Private and confidential
Page 111 - Private and confidential
Page 112 - Private and confidential
Page 113 - Private and confidential
Page 114 - Private and confidential
Page 115 - Private and confidential
Page 116 - Private and confidential
Page 117 - Private and confidential
Page 118 - Private and confidential
Page 119 - Private and confidential
Page 120 - Private and confidential
Page 121 - EXHIBIT 4
Page 122 - Private and confidential
Page 123 - Private and confidential
Page 124 - Private and confidential
Page 125 - Private and confidential
Page 126 - Private and confidential
Page 127 - Private and confidential
Page 128 - Private and confidential
Page 129 - Private and confidential
Page 130 - Private and confidential
Page 131 - Private and confidential
Page 132 - Private and confidential
Page 133 - Private and confidential
Page 134 - Private and confidential
Page 135 - Private and confidential
Page 136 - Private and confidential
Page 137 - Private and confidential
Page 138 - Private and confidential
Page 139 - Private and confidential
Page 140 - Private and confidential
Page 141 - Private and confidential
Page 142 - Private and confidential
Page 143 - Private and confidential
Page 144 - Private and confidential
Page 145 - Private and confidential
Page 146 - Private and confidential
Page 147 - Private and confidential
Page 148 - Private and confidential
Page 149 - Private and confidential
Page 150 - Private and confidential
Page 151 - Private and confidential
Subdocument 3 - EX-99.1 - PRESS RELEASE ISSUED BY ACTAVIS, INC. (FORMERLY WATSON PHARMACEUTICALS, INC.)
Page 1 - Exhibit 99.1
Page 2 - Near-Term Product Opportunities
Page 3 - Mid Stage Development Candidate
Page 4 - About Uteron
Page 5 - N/A
ELECTRONIC ENROLLMENT